273 related articles for article (PubMed ID: 31989145)
1. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
[TBL] [Abstract][Full Text] [Related]
2. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
[TBL] [Abstract][Full Text] [Related]
3. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry.
Baudy AR; Otieno MA; Hewitt P; Gan J; Roth A; Keller D; Sura R; Van Vleet TR; Proctor WR
Lab Chip; 2020 Jan; 20(2):215-225. PubMed ID: 31799979
[TBL] [Abstract][Full Text] [Related]
4. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.
Ainslie GR; Davis M; Ewart L; Lieberman LA; Rowlands DJ; Thorley AJ; Yoder G; Ryan AM
Lab Chip; 2019 Sep; 19(19):3152-3161. PubMed ID: 31469131
[TBL] [Abstract][Full Text] [Related]
5. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
[TBL] [Abstract][Full Text] [Related]
6. Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications.
Fabre K; Berridge B; Proctor WR; Ralston S; Will Y; Baran SW; Yoder G; Van Vleet TR
Lab Chip; 2020 Mar; 20(6):1049-1057. PubMed ID: 32073020
[TBL] [Abstract][Full Text] [Related]
7. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
Baran SW; Brown PC; Baudy AR; Fitzpatrick SC; Frantz C; Fullerton A; Gan J; Hardwick RN; Hillgren KM; Kopec AK; Liras JL; Mendrick DL; Nagao R; Proctor WR; Ramsden D; Ribeiro AJS; Stresser D; Sung KE; Sura R; Tetsuka K; Tomlinson L; Van Vleet T; Wagoner MP; Wang Q; Arslan SY; Yoder G; Ekert JE
ALTEX; 2022; 39(2):297–314. PubMed ID: 35064273
[TBL] [Abstract][Full Text] [Related]
9. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
Hughes DJ; Kostrzewski T; Sceats EL
Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays.
Hardwick RN; Betts CJ; Whritenour J; Sura R; Thamsen M; Kaufman EH; Fabre K
Lab Chip; 2020 Jan; 20(2):199-214. PubMed ID: 31598618
[TBL] [Abstract][Full Text] [Related]
11. The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline.
Sutherland ML; Fabre KM; Tagle DA
Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):I1. PubMed ID: 24565163
[TBL] [Abstract][Full Text] [Related]
12. Imaging microphysiological systems: a review.
Peel S; Jackman M
Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
[TBL] [Abstract][Full Text] [Related]
13. Drug testing and characterization using human-on-chip (HoC) systems: some thoughts on the application of in vitro-in vivo correlation.
Somayaji MR; Das D; Przekwas AJ
Drug Discov Today; 2018 Sep; 23(9):1571-1573. PubMed ID: 29428643
[No Abstract] [Full Text] [Related]
14. A thermoplastic microfluidic microphysiological system to recapitulate hepatic function and multicellular interactions.
Bale SS; Manoppo A; Thompson R; Markoski A; Coppeta J; Cain B; Haroutunian N; Newlin V; Spencer A; Azizgolshani H; Lu M; Gosset J; Keegan P; Charest JL
Biotechnol Bioeng; 2019 Dec; 116(12):3409-3420. PubMed ID: 30963546
[TBL] [Abstract][Full Text] [Related]
15. Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator.
Kanamori T; Sugiura S; Sakai Y
Drug Metab Pharmacokinet; 2018 Feb; 33(1):40-42. PubMed ID: 29217459
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics-On-a-Chip: In Vitro Microphysiological Models for Emulating of Drugs ADME.
Ramadan Q; Fardous RS; Hazaymeh R; Alshmmari S; Zourob M
Adv Biol (Weinh); 2021 Sep; 5(9):e2100775. PubMed ID: 34323392
[TBL] [Abstract][Full Text] [Related]
17. Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips.
Prantil-Baun R; Novak R; Das D; Somayaji MR; Przekwas A; Ingber DE
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():37-64. PubMed ID: 29309256
[TBL] [Abstract][Full Text] [Related]
18. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
19. Kidney-on-a-chip: untapped opportunities.
Ashammakhi N; Wesseling-Perry K; Hasan A; Elkhammas E; Zhang YS
Kidney Int; 2018 Dec; 94(6):1073-1086. PubMed ID: 30366681
[TBL] [Abstract][Full Text] [Related]
20. Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies.
Ishida S
Drug Metab Pharmacokinet; 2018 Feb; 33(1):49-54. PubMed ID: 29398302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
